Vantage Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-200
Closed -$16K 764
2018
Q1
$16K Buy
200
+125
+167% +$10K ﹤0.01% 464
2017
Q4
$7K Buy
+75
New +$7K ﹤0.01% 630
2016
Q3
Sell
-75
Closed -$6K 782
2016
Q2
$6K Hold
75
﹤0.01% 595
2016
Q1
$6K Buy
+75
New +$6K ﹤0.01% 590